相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R. Lord et al.
CELL METABOLISM (2018)
Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers
Xiaojing Liu et al.
Cell Metabolism (2016)
Impact of metformin on metastases in patients with breast cancer and type 2 diabetes
Louis Jacob et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
Roman Camarda et al.
NATURE MEDICINE (2016)
Fatty Acid Oxidation-Driven Src Links Mitochondrial Energy Reprogramming and Oncogenic Properties in Triple-Negative Breast Cancer
Jun Hyoung Park et al.
CELL REPORTS (2016)
Inhibition of fatty acid desaturation is detrimental to cancer cell survival in metabolically compromised environments
Barrie Peck et al.
CANCER & METABOLISM (2016)
Preclinical Evaluation of 3-18F-Fluoro-2,2-Dimethylpropionic Acid as an Imaging Agent for Tumor Detection
Timothy H. Witney et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Kivanc Birsoy et al.
NATURE (2014)
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
Sarah-Maria Fendt et al.
CANCER RESEARCH (2013)
Regulation of lipid droplet size and phospholipid composition by stearoyl-CoA desaturase
Xun Shi et al.
JOURNAL OF LIPID RESEARCH (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer metabolism: fatty acid oxidation in the limelight
Arkaitz Carracedo et al.
NATURE REVIEWS CANCER (2013)
Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin
Shiva Javeshghani et al.
CANCER RESEARCH (2012)
A PML-PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance
Keisuke Ito et al.
NATURE MEDICINE (2012)
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
Chang W. Song et al.
SCIENTIFIC REPORTS (2012)
De novo lipogenesis in the differentiating human adipocyte can provide all fatty acids necessary for maturation
Jennifer M. Collins et al.
JOURNAL OF LIPID RESEARCH (2011)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
De Novo Lipogenesis and Stearoyl-CoA Desaturase Are Coordinately Regulated in the Human Adipocyte and Protect against Palmitate-induced Cell Injury
Jennifer M. Collins et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction
Ismael Samudio et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Crucial role for LKB1 to AMPK alpha 2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes
Daphna D. J. Habets et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms
Ramesh Saeedi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes
Christine Desmedt et al.
CLINICAL CANCER RESEARCH (2008)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action
Yan Shu et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin
Eriko Shikata et al.
JOURNAL OF HUMAN GENETICS (2007)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells
MW Zang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
LL Listenberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats
RL Dobbins et al.
DIABETES (2001)
分享论文
